Skip to main content
    B

    BioRestorative Therapies Inc (BRTX)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $1.34
    -0.08 (-5.63%)

    Market Cap: $1.96M

    Last updated: Nov 17, 2026 at 4:10 PM ET

    BioRestorative Therapies Inc (BRTX) Valuation Multiples

    Updated Nov 17, 2026. Multiples are computed from end-of-day prices, company filings and consensus analyst estimates.

    BioRestorative Therapies (BRTX) trades at 66.4x sales and 7.9x book value. Its P/B of 7.9x is below its 5-year median of 23.7x.

    Current Multiples

    MultipleValue
    P/E (trailing)N/A
    Forward P/EN/A
    Price to sales66.4x
    Price to book7.9x
    PEGN/A
    As of Nov 17, 2026

    Historical Medians

    MultipleCurrent5-year median10-year median
    P/B7.9x23.7xN/A
    Medians of month-end values through Oct 2026: 55 months (5-year).

    Valuation History

    Over the 5 of the 10 year ends shown that have a P/S, its P/S ranged from 100.6x in 2021 to 971.1x in 2023.

    Year endPriceP/SP/B
    2025$23.50570.5x584.7x
    2024$28.60565.7x26.0x
    2023$34.80971.1x16.4x
    2022$55.00N/A19.6x
    2021$86.80100.6xN/A
    2020$460.00109.4xN/A
    2019$333.33N/AN/A
    2018$60,000.00N/AN/A
    2017$246,666.67N/AN/A
    2016$220,000.00N/AN/A
    Each year's multiples use the split-adjusted closing price of that year's last trading day over trailing per-share results as reported.

    Frequently Asked Questions About BRTX

    What is BRTX's price to sales ratio?

    BioRestorative Therapies has a price to sales ratio of 66.4x.